Delivery Order SPE2DB24D2109-SPE2DB24FHWBX
Award Date
8/26/24
Potential Completion Date
8/27/24
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, with Amerisourcebergen Drug Corp's Corporate Office Division. The $43,451.24 firm fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 21, 2024, and was awarded on August 20, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML medication to the Defense Logistics Agency (DLA). The $1,053.68 firm fixed-price delivery order has a completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division, is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $29,741.46 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) and has a completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract without any set-aside designation. The company has a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $3,156.00 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), which is a defense agency. The contract has a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The award, valued at $8,630.50, was made by the Defense Logistics Agency (DLA) and has a completion date of June 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a $6,669.14 Firm Fixed Price Delivery Order for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is valued at $3,717.48 and delivers the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 17, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp, Corporate Office Division, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and has a ceiling value of $2,802.89. The contract is a Delivery Order with a Firm Fixed Price pricing type, has no set-aside designation, and has an ultimate completion date of August 28, 2024....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price of $1,052.00 and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order worth $26,500.40 for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract has a firm fixed price and a completion date of May 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a particular focus on serving the Department of Defense (DoD) and...